Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I. in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
Fox Chase Cancer Center /Inc/
Search grants from Fox Chase Cancer Center /Inc/
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mid-level mechanisms of surface and binocular perception
Regulation of Protein Turnover in Sepsis
Sequencing and Initiation in Speech Production
Cone Degeneration - Structural and Functional Studies
Human X - Cytologic vs. Molecular and Genetic Data
Recently added grants:
Endothelial Sphingolipid Synthesis and Tissue Inflammatory Response
Comprehensive Magnetic Resonance in PAD
Short-Term Training Program to Increase Diversity in Health-Related Research
Neurocognitive effects of iron deficiency in blood donors.
The Role of Phosphatidylinositides in Lipid Metabolism
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN025120-001
Application #
6994820
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center /Inc/
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
/ Fox Chase Cancer Center /Inc/
NIH 2005
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
/ Fox Chase Cancer Center /Inc/
NIH 2004
N01 CN
Phase I. in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
/ Fox Chase Cancer Center /Inc/
Comments
Be the first to comment on this grant